IL-18 expression is elevated in the blood serum of CRC patients and is associated with tumor size, histological grade, and cancer cell metastasis, making it a potential indicator to predict CRC patients’ prognosis and survival time [143]. Here, IL18 is linked to colorectal carcinoma.